TTM
$7.12M
YoY change
+1181.3%
5Y CAGR
-10.5%
Peak year (2021)
$208.38M
Cumulative revenue
$230.71M
Revenue history chart for Ovid Therapeutics (OVID) from 2014 to 2025
Latest: $7.25M
Revenue growth chart for Ovid Therapeutics (OVID) from 2014 to 2025
Latest: +1181.3%
Revenue history table for Ovid Therapeutics (OVID) from 2014 to 2025
| 2025 | $7.25M | +1181.3% | +$6.69M | ||
| 2024 | $566.00K | +44.4% | +$174.00K | ||
| 2023 | $392.00K | -73.9% | −$1.11M | ||
| 2022 | $1.50M | -99.3% | −$206.88M | ||
| 2021 | $208.38M | +1551.6% | +$195.77M | ||
| 2020 | $12.62M | — | +$12.62M | ||
| 2019 | $0.00 | — | $0.00 | ||
| 2018 | $0.00 | — | $0.00 | ||
| 2017 | $0.00 | — | $0.00 | ||
| 2016 | $0.00 | — | $0.00 | ||
| 2015 | $0.00 | — | $0.00 | ||
| 2014 | $0.00 | — | — |
- 2025$7.25M+1181.3%
- 2024$566.00K+44.4%
- 2023$392.00K-73.9%
- 2022$1.50M-99.3%
- 2021$208.38M+1551.6%
- 2020$12.62M—
- 2019$0.00—
- 2018$0.00—
- 2017$0.00—
- 2016$0.00—
- 2015$0.00—
- 2014$0.00—
Revenue values are taken from Ovid Therapeutics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Revenue at Ovid Therapeutics (OVID)
According to Ovid Therapeutics's latest reported financial statements, the company's current revenue (TTM) is $7.12M. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Ovid Therapeutics (OVID) revenue totalled $7.25M – surged 1181.3% year-over-year.
Through 2020–2025 (5 years), Ovid Therapeutics revenue delivered a -10.5% annualised rate; sustaining 2 straight years of year-over-year growth.
Ovid Therapeutics revenue peaked at $208.38M in 2021; the latest annual figure is $7.25M in 2025 (96.5% below peak).
The highest annual revenue of $208.38M was reported in 2021. The lowest in the available history was $0.00 in 2014.
Ovid Therapeutics Revenue by Year
Ovid Therapeutics Revenue 2025: $7.25M
Ovid Therapeutics posted revenue of $7.25M in 2025, surged 1181.3% from 2024.
Ovid Therapeutics Revenue 2024: $566.00K
In 2024, Ovid Therapeutics reported revenue of $566.00K, surged 44.4% from 2023.
Ovid Therapeutics Revenue 2023: $392.00K
Ovid Therapeutics revenue in 2023 was $392.00K, plunged 73.9% below 2022.
Ovid Therapeutics Revenue 2022: $1.50M
2022's revenue for Ovid Therapeutics came in at $1.50M, plunged 99.3% below 2021.
Ovid Therapeutics Revenue 2021: $208.38M
Ovid Therapeutics revenue in 2021 was $208.38M.
See more financial history for Ovid Therapeutics (OVID).
Sector peers by Revenue
Healthcare peers of Ovid Therapeutics (OVID), ranked by their latest revenue
| $447.57B | |
| $94.19B | |
| $65.18B | |
| $64.93B | |
| $61.16B | |
| $58.74B | |
| $48.18B | |
| $36.74B |
- $447.57B
- $94.19B
- $65.18B
- $64.93B
- $61.16B
- $58.74B
- $48.18B
- $36.74B
Frequently asked questions
Ovid Therapeutics (OVID) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation